Albus Health key facts
as of Oct 2026- Developer of a non-contact respiratory monitoring system designed to provide personalized monitoring at home.
- Albus Health is valued at approximately $11.1M as of Oct 2026 (last reported valuation).
- It has raised $4.6M; the latest was Later Stage VC ($4.0M) in Dec 2024.
- Notable investors include Innovate UK, Creative Destruction Lab, Parkwalk Advisors, University of Oxford, Possible Ventures — 15 tracked in total.
- Status: Privately Held (backing).
Albus Health's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Albus Health: the Monday email on marks, rounds and moves
Albus Health funding rounds
No funding rounds for Albus Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Albus Health
15+Albus Health valuation
Albus Health's last reported valuation was $11.1 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Albus Health investors
15 investors are on record for Albus Health, including Innovate UK, Creative Destruction Lab, Parkwalk Advisors and University of Oxford.
About Albus Health
Developer of a non-contact respiratory monitoring system designed to provide personalized monitoring at home. The company's platform offers passive, contactless, and objective monitoring of a range of symptoms and environmental metrics at home, enabling pharma companies to generate more revenue from their drugs while de-risking, optimizing,g and scaling their clinical studies.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2017
- Employees
- 11
- Website
- albushealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.